Remove Immune Response Remove Pharma Companies Remove Protein
article thumbnail

UK Pharma Company Scancell Selects COVID-19 Vaccine for Clinical Trials | 2020-12-21

The Pharma Data

SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology. The company, along with partners University of Nottingham and Trent University, received a British government grant to support the study. . Source link.

article thumbnail

Cancer vaccines: providing the edge in oncology

pharmaphorum

While therapeutic cancer vaccines are able to help the body identify particular proteins expressed by cancer cells and then to instigate an immune response. Larger companies that are working in the space, such as Moderna, share the same belief, but with another approach. A broad front.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COVID prompts another milestone, as India clears first DNA vaccine

pharmaphorum

DNA vaccines work by delivering a genetically-engineered plasmid containing the DNA sequence encoding the desired antigen – in this case the SARS-CoV-2 spike protein – which is then taken up by cells. The company also says that it can update the vaccine very easily to deal with mutations in the virus.

DNA 98
article thumbnail

FDA guidance allows fast updates of COVID-19 vaccines

pharmaphorum

Changes in the “Spike” protein targeted by nearly all the vaccines approved or in development could also lead to more infectious variants, such as the strain that emerged in Kent and is now prevalent across most of the UK. Manufacturers are also encouraged to study the response in previously vaccinated and unvaccinated people.

article thumbnail

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

pharmaphorum

Sanofi is the first pharma company to partner with Baidu on its LinearDesign AI platform, which has been developed specifically to optimise the sequence of mRNA-based vaccines and drugs. Specific financial terms have not been disclosed.

Licensing 105
article thumbnail

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

XTalks

chimeric receptor antigen [CAR] T cell) immune modulators (i.e. protein-based biologics) and vaccine treatments. Immune checkpoint inhibitors : these are drugs that block immune checkpoints, allowing immune cells to elicit enhanced responses to cancer cells. Immune system modulators (i.e.

Protein 98
article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

In 2018 the research firm Reputation Institute ranked Pfizer’s reputation at rock bottom on a list of 22 pharma companies – and none of them ranked highly against other sectors! In 2017 Pfizer was one of the top ten US donors of charitable aid, to the tune of a staggering $210million (or 1.7%

Branding 112